ARTG Entry
OLMEKAR
ARTG entry for OLMEKAR (amlodipine, olmesartan medoxomil), ARTG 290077 — Product Information, dosage form, registration history. Compiled by arcimedes.
- Sponsor: Arrotex Pharmaceuticals
- Active ingredient: amlodipine, olmesartan medoxomil
- Therapeutic area: Cardiology
I cannot write a Brand Dossier for OLMEKAR based on the provided documents.
The source documents contain information about two different medicines:
1. **Document 1** describes a triple-combination product (amlodipine/valsartan/hydrochlorothiazide) branded as OLMEKAR, sponsored by Novartis.
2. **Document 2** describes a dual-combination product (olmesartan medoxomil/amlodipine) branded as OLMEKAR, sponsored by Arrotex Pharmaceuticals.
These are distinct medicines with different active ingredients and different sponsors. The instructions require me to write about "a registered Australian medicine" (singular) with a specific brand name, but the documents refer to products with the same brand name but fundamentally different compositions.
Additionally, Document 1 does not contain key information required for a complete Brand Dossier, such as: — PBS listing details (strength, item count, restriction type, ex-manufacturer price) — Regulatory history (ARTG registration date, PBAC outcome dates, AusPAR reference)
To proceed, I would need: — Clarification of which OLMEKAR product should be documented — Complete regulatory and PBS information for that specific product — Consistency between the brand name and the active ingredient(s) described
Please provide the correct source document for the specific OLMEKAR variant you wish documented.